Dimensional Fund Advisors
SCPH

Dimensional Fund Advisors’s scPharmaceuticals SCPH Stock Holding History

Dimensional Fund Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33,152
Closed -$151K – 3359
2024
Q3 		$151K Sell
33,152
-101,928
-75% -$493K ﹤0.01% 3201
2024
Q2 		$588K Sell
135,080
-31,136
-19% -$137K ﹤0.01% 3002
2024
Q1 		$834K Sell
166,216
-7,357
-4% -$41.2K ﹤0.01% 2950
2023
Q4 		$1.09M Sell
173,573
-27,230
-14% -$156K ﹤0.01% 2917
2023
Q3 		$1.43M Sell
200,803
-6,470
-3% -$51K ﹤0.01% 2848
2023
Q2 		$2.11M Hold
207,273
– – ﹤0.01% 2770
2023
Q1 		$1.88M Buy
+207,273
New +$1.52M ﹤0.01% 2756
2022
Q3 		$906K Buy
139,119
+22,677
+19% +$121K ﹤0.01% 2905
2022
Q2 		$561K Buy
116,442
+12,908
+12% +$63.9K ﹤0.01% 3039
2022
Q1 		$588K Buy
103,534
+6,787
+7% +$33.3K ﹤0.01% 3109
2021
Q4 		$485K Buy
96,747
+17,482
+22% +$96.2K ﹤0.01% 3173
2021
Q3 		$527K Buy
79,265
+34,438
+77% +$206K ﹤0.01% 3166
2021
Q2 		$273K Sell
44,827
-2,051
-4% -$12.4K ﹤0.01% 3278
2021
Q1 		$311K Hold
46,878
– – ﹤0.01% 3218
2020
Q4 		$248K Buy
46,878
+2,644
+6% +$20.7K ﹤0.01% 3199
2020
Q3 		$330K Buy
44,234
+17,884
+68% +$140K ﹤0.01% 3136
2020
Q2 		$194K Buy
26,350
+10,480
+66% +$92.1K ﹤0.01% 3213
2020
Q1 		$117K Buy
+15,870
New +$115K ﹤0.01% 3263

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Dimensional Fund Advisors's SCPH Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of scPharmaceuticals (SCPH) in Q4 2024, closing a stake of 33,152 shares — an estimated $151K sold.

Dimensional Fund Advisors first reported a position in SCPH in Q1 2020 and held it in 18 quarters. The position peaked at $2.11M in Q2 2023. 85 funds tracked by Wall St. Rank hold SCPH as of Q4 2024.

  • Dimensional Fund Advisors reported no remaining scPharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 33,152 scPharmaceuticals shares in Q4 2024, an estimated $151K.
  • Dimensional Fund Advisors first reported a position in scPharmaceuticals in Q1 2020 and held it in 18 quarters.
  • Dimensional Fund Advisors's scPharmaceuticals position peaked at $2.11M in Q2 2023.
  • 85 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.